J. Safra Sarasin Holding Ag Madrigal Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.47 Trillion
- Q2 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 5,751 shares of MDGL stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,751Holding current value
$1.34 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
22MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$580 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$479 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$460 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$447 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$431 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.99B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...